Devonian Health Group Inc. Logo

Devonian Health Group Inc. (DVHGF)

OTC

Currency in USD
4.94
-0.84 (-14.53%)

Closed

Oct 6, 2026

Day's Range

4.94
4.95

52 wk Range

4.27
10.65

Overview - DVHGF - Devonian Health Group Inc.

Key Statistics

Valuation

Enterprise Value

11.06M

P/E (Trailing)

‪-2.38‬

PEG Ratio

‪0.03‬

Price / Sales (TTM)

‪5.45‬

Price / Book

‪3.30‬

EV / EBITDA

‪-2.66‬

Profitability

Gross Margin

‪111.29%‬

Profit Margin

‪-204.08%‬

Operating Margin

‪-1,096.22%‬

Return on Assets

‪-24.50%‬

Return on Equity

‪-77.32%‬

Ownership

Shares Outstanding

2.78M

Float

2.10M

Held by Insiders

‪12.03%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪1.24‬

50-Day Avg

‪11.50‬

200-Day Avg

‪11.50‬

Shariah Compliance

Questionable Compliance

Report Date: Feb 15, 2025

Screened by Zoya using the AAOIFI methodology.

News Teaser - DVHGF - Devonian Health Group Inc.

News & Analysis

View all news

Market Cap - DVHGF - Devonian Health Group Inc.

Peers - DVHGF - Devonian Health Group Inc.

Peer Comparison

Compared with companies in Biotechnology listed on OTC.

Profile Summary - DVHGF - Devonian Health Group Inc.

About

Devonian Health Group Inc. is a pharmaceutical company specializing in the development and commercialization of botanical drugs and cosmeceutical products. Focusing on leveraging plant-based compounds, Devonian Health aims to address niche markets in dermatology, particularly targeting anti-aging and anti-inflammatory…

SectorHealthcare
IndustryBiotechnology
Employees8
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.